nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CYP2C9—cardial valve—dilated cardiomyopathy	0.0333	0.202	CbGeAlD
Tretinoin—RARRES1—myocardium—dilated cardiomyopathy	0.0163	0.0988	CbGeAlD
Tretinoin—RARRES1—heart—dilated cardiomyopathy	0.0114	0.069	CbGeAlD
Tretinoin—RARRES1—cardiac atrium—dilated cardiomyopathy	0.00975	0.059	CbGeAlD
Tretinoin—ALDH1A1—cardiac ventricle—dilated cardiomyopathy	0.00969	0.0586	CbGeAlD
Tretinoin—ALDH1A1—myocardium—dilated cardiomyopathy	0.00911	0.0551	CbGeAlD
Tretinoin—RXRB—myocardium—dilated cardiomyopathy	0.00899	0.0544	CbGeAlD
Tretinoin—ALDH1A2—heart—dilated cardiomyopathy	0.00875	0.0529	CbGeAlD
Tretinoin—RARB—heart—dilated cardiomyopathy	0.00683	0.0413	CbGeAlD
Tretinoin—RXRG—heart—dilated cardiomyopathy	0.00667	0.0404	CbGeAlD
Tretinoin—ALDH1A1—heart—dilated cardiomyopathy	0.00636	0.0385	CbGeAlD
Tretinoin—RXRB—heart—dilated cardiomyopathy	0.00627	0.038	CbGeAlD
Tretinoin—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00568	0.0111	CcSEcCtD
Tretinoin—Flank pain—Lisinopril—dilated cardiomyopathy	0.00561	0.011	CcSEcCtD
Tretinoin—RARG—heart—dilated cardiomyopathy	0.00557	0.0337	CbGeAlD
Tretinoin—Local reaction—Furosemide—dilated cardiomyopathy	0.00544	0.0106	CcSEcCtD
Tretinoin—ALDH1A1—cardiac atrium—dilated cardiomyopathy	0.00544	0.0329	CbGeAlD
Tretinoin—RXRB—cardiac atrium—dilated cardiomyopathy	0.00537	0.0325	CbGeAlD
Tretinoin—RARA—heart—dilated cardiomyopathy	0.00524	0.0317	CbGeAlD
Tretinoin—Lung infiltration—Lisinopril—dilated cardiomyopathy	0.00482	0.00943	CcSEcCtD
Tretinoin—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.0046	0.00899	CcSEcCtD
Tretinoin—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00436	0.00852	CcSEcCtD
Tretinoin—Thrombosis—Furosemide—dilated cardiomyopathy	0.00426	0.00833	CcSEcCtD
Tretinoin—Ear disorder—Lisinopril—dilated cardiomyopathy	0.00419	0.00819	CcSEcCtD
Tretinoin—Blister—Furosemide—dilated cardiomyopathy	0.00418	0.00818	CcSEcCtD
Tretinoin—Lethargy—Spironolactone—dilated cardiomyopathy	0.0041	0.00802	CcSEcCtD
Tretinoin—Blindness—Lisinopril—dilated cardiomyopathy	0.00408	0.00799	CcSEcCtD
Tretinoin—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.00368	0.00719	CcSEcCtD
Tretinoin—Fluid overload—Lisinopril—dilated cardiomyopathy	0.00364	0.00711	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00362	0.00708	CcSEcCtD
Tretinoin—Gastritis—Spironolactone—dilated cardiomyopathy	0.00356	0.00696	CcSEcCtD
Tretinoin—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.00352	0.00689	CcSEcCtD
Tretinoin—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00325	0.00635	CcSEcCtD
Tretinoin—Drug interaction—Furosemide—dilated cardiomyopathy	0.00325	0.00635	CcSEcCtD
Tretinoin—Gout—Furosemide—dilated cardiomyopathy	0.00323	0.00631	CcSEcCtD
Tretinoin—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00317	0.00619	CcSEcCtD
Tretinoin—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00314	0.00613	CcSEcCtD
Tretinoin—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0031	0.00606	CcSEcCtD
Tretinoin—Vasculitis—Furosemide—dilated cardiomyopathy	0.00309	0.00604	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00307	0.00601	CcSEcCtD
Tretinoin—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00307	0.006	CcSEcCtD
Tretinoin—Renal failure—Spironolactone—dilated cardiomyopathy	0.00305	0.00596	CcSEcCtD
Tretinoin—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00295	0.00577	CcSEcCtD
Tretinoin—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.00292	0.0176	CbGeAlD
Tretinoin—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00289	0.00565	CcSEcCtD
Tretinoin—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00288	0.00563	CcSEcCtD
Tretinoin—Bladder pain—Furosemide—dilated cardiomyopathy	0.00273	0.00533	CcSEcCtD
Tretinoin—Lightheadedness—Furosemide—dilated cardiomyopathy	0.0027	0.00527	CcSEcCtD
Tretinoin—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00263	0.00514	CcSEcCtD
Tretinoin—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00257	0.00503	CcSEcCtD
Tretinoin—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00256	0.005	CcSEcCtD
Tretinoin—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00254	0.00496	CcSEcCtD
Tretinoin—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00252	0.00492	CcSEcCtD
Tretinoin—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00249	0.00487	CcSEcCtD
Tretinoin—Swelling—Furosemide—dilated cardiomyopathy	0.00248	0.00485	CcSEcCtD
Tretinoin—Alopecia—Spironolactone—dilated cardiomyopathy	0.00246	0.00481	CcSEcCtD
Tretinoin—Deafness—Furosemide—dilated cardiomyopathy	0.00245	0.00478	CcSEcCtD
Tretinoin—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00244	0.00477	CcSEcCtD
Tretinoin—Gout—Lisinopril—dilated cardiomyopathy	0.00242	0.00474	CcSEcCtD
Tretinoin—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00241	0.0047	CcSEcCtD
Tretinoin—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00232	0.00453	CcSEcCtD
Tretinoin—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00232	0.00453	CcSEcCtD
Tretinoin—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00229	0.00448	CcSEcCtD
Tretinoin—Neck pain—Lisinopril—dilated cardiomyopathy	0.00229	0.00448	CcSEcCtD
Tretinoin—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00229	0.00448	CcSEcCtD
Tretinoin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00225	0.00439	CcSEcCtD
Tretinoin—Lethargy—Furosemide—dilated cardiomyopathy	0.00223	0.00437	CcSEcCtD
Tretinoin—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00221	0.00432	CcSEcCtD
Tretinoin—Wheezing—Lisinopril—dilated cardiomyopathy	0.0022	0.00429	CcSEcCtD
Tretinoin—Malaise—Spironolactone—dilated cardiomyopathy	0.00218	0.00427	CcSEcCtD
Tretinoin—Cystitis—Lisinopril—dilated cardiomyopathy	0.00218	0.00427	CcSEcCtD
Tretinoin—Photophobia—Lisinopril—dilated cardiomyopathy	0.00212	0.00415	CcSEcCtD
Tretinoin—Irritability—Furosemide—dilated cardiomyopathy	0.00209	0.00408	CcSEcCtD
Tretinoin—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00205	0.00401	CcSEcCtD
Tretinoin—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00204	0.004	CcSEcCtD
Tretinoin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00204	0.00398	CcSEcCtD
Tretinoin—Dehydration—Furosemide—dilated cardiomyopathy	0.00203	0.00398	CcSEcCtD
Tretinoin—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00202	0.00396	CcSEcCtD
Tretinoin—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00201	0.00394	CcSEcCtD
Tretinoin—Confusional state—Spironolactone—dilated cardiomyopathy	0.00199	0.0039	CcSEcCtD
Tretinoin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00198	0.00386	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00197	0.00385	CcSEcCtD
Tretinoin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00194	0.00378	CcSEcCtD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00192	0.00595	CbGpPWpGaD
Tretinoin—RXRB—a6b1 and a6b4 Integrin signaling—RAC1—dilated cardiomyopathy	0.00192	0.00594	CbGpPWpGaD
Tretinoin—CYP1A1—heart—dilated cardiomyopathy	0.00191	0.0116	CbGeAlD
Tretinoin—Abdominal distension—Furosemide—dilated cardiomyopathy	0.0019	0.00372	CcSEcCtD
Tretinoin—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00189	0.00369	CcSEcCtD
Tretinoin—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00187	0.00366	CcSEcCtD
Tretinoin—CYP2B6—heart—dilated cardiomyopathy	0.00186	0.0113	CbGeAlD
Tretinoin—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00185	0.00362	CcSEcCtD
Tretinoin—CYP2C9—heart—dilated cardiomyopathy	0.00184	0.0111	CbGeAlD
Tretinoin—Eczema—Lisinopril—dilated cardiomyopathy	0.00183	0.00357	CcSEcCtD
Tretinoin—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.0018	0.00352	CcSEcCtD
Tretinoin—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00178	0.00348	CcSEcCtD
Tretinoin—Somnolence—Spironolactone—dilated cardiomyopathy	0.00176	0.00344	CcSEcCtD
Tretinoin—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00175	0.00342	CcSEcCtD
Tretinoin—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00173	0.00337	CcSEcCtD
Tretinoin—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00172	0.00337	CcSEcCtD
Tretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—RPS6KB1—dilated cardiomyopathy	0.00172	0.00531	CbGpPWpGaD
Tretinoin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00171	0.00334	CcSEcCtD
Tretinoin—Arthritis—Lisinopril—dilated cardiomyopathy	0.00169	0.0033	CcSEcCtD
Tretinoin—Drowsiness—Furosemide—dilated cardiomyopathy	0.00169	0.0033	CcSEcCtD
Tretinoin—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00168	0.00328	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00167	0.00327	CcSEcCtD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.00166	0.00513	CbGpPWpGaD
Tretinoin—Renal failure—Furosemide—dilated cardiomyopathy	0.00166	0.00324	CcSEcCtD
Tretinoin—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00164	0.00321	CcSEcCtD
Tretinoin—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00164	0.00321	CcSEcCtD
Tretinoin—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.00164	0.00991	CbGeAlD
Tretinoin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00163	0.00318	CcSEcCtD
Tretinoin—Sweating—Furosemide—dilated cardiomyopathy	0.00162	0.00316	CcSEcCtD
Tretinoin—Face oedema—Lisinopril—dilated cardiomyopathy	0.00158	0.0031	CcSEcCtD
Tretinoin—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00157	0.00308	CcSEcCtD
Tretinoin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00157	0.00307	CcSEcCtD
Tretinoin—Irritability—Lisinopril—dilated cardiomyopathy	0.00157	0.00306	CcSEcCtD
Tretinoin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00156	0.00306	CcSEcCtD
Tretinoin—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00156	0.00305	CcSEcCtD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.00156	0.00481	CbGpPWpGaD
Tretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—SDHA—dilated cardiomyopathy	0.00156	0.00481	CbGpPWpGaD
Tretinoin—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00154	0.00301	CcSEcCtD
Tretinoin—Dehydration—Lisinopril—dilated cardiomyopathy	0.00153	0.00298	CcSEcCtD
Tretinoin—RXRG—Adipogenesis—LMNA—dilated cardiomyopathy	0.00152	0.00472	CbGpPWpGaD
Tretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.0015	0.00464	CbGpPWpGaD
Tretinoin—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00149	0.00292	CcSEcCtD
Tretinoin—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00148	0.0029	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00148	0.00289	CcSEcCtD
Tretinoin—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00147	0.00287	CcSEcCtD
Tretinoin—Visual impairment—Furosemide—dilated cardiomyopathy	0.00146	0.00285	CcSEcCtD
Tretinoin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00146	0.00285	CcSEcCtD
Tretinoin—Gastritis—Lisinopril—dilated cardiomyopathy	0.00145	0.00284	CcSEcCtD
Tretinoin—RARA—Adipogenesis—LMNA—dilated cardiomyopathy	0.00143	0.00444	CbGpPWpGaD
Tretinoin—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00143	0.0028	CcSEcCtD
Tretinoin—Asthma—Lisinopril—dilated cardiomyopathy	0.00142	0.00277	CcSEcCtD
Tretinoin—NR0B1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.00141	0.00438	CbGpPWpGaD
Tretinoin—Eye disorder—Furosemide—dilated cardiomyopathy	0.00141	0.00277	CcSEcCtD
Tretinoin—Tinnitus—Furosemide—dilated cardiomyopathy	0.00141	0.00276	CcSEcCtD
Tretinoin—Pruritus—Spironolactone—dilated cardiomyopathy	0.0014	0.00273	CcSEcCtD
Tretinoin—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.0014	0.00273	CcSEcCtD
Tretinoin—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00139	0.00272	CcSEcCtD
Tretinoin—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00138	0.0027	CcSEcCtD
Tretinoin—Angiopathy—Furosemide—dilated cardiomyopathy	0.00137	0.00269	CcSEcCtD
Tretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.00137	0.00424	CbGpPWpGaD
Tretinoin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00135	0.00264	CcSEcCtD
Tretinoin—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00135	0.00264	CcSEcCtD
Tretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.00134	0.00416	CbGpPWpGaD
Tretinoin—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00133	0.00259	CcSEcCtD
Tretinoin—Dysuria—Lisinopril—dilated cardiomyopathy	0.00133	0.00259	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00132	0.00258	CcSEcCtD
Tretinoin—Erythema—Furosemide—dilated cardiomyopathy	0.00132	0.00258	CcSEcCtD
Tretinoin—Malnutrition—Furosemide—dilated cardiomyopathy	0.00132	0.00258	CcSEcCtD
Tretinoin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00131	0.00256	CcSEcCtD
Tretinoin—Flatulence—Furosemide—dilated cardiomyopathy	0.0013	0.00254	CcSEcCtD
Tretinoin—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.0013	0.00253	CcSEcCtD
Tretinoin—Weight increased—Lisinopril—dilated cardiomyopathy	0.00129	0.00252	CcSEcCtD
Tretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.00129	0.00399	CbGpPWpGaD
Tretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.00129	0.00399	CbGpPWpGaD
Tretinoin—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00128	0.00251	CcSEcCtD
Tretinoin—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00127	0.00249	CcSEcCtD
Tretinoin—CYP4A11—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00126	0.00391	CbGpPWpGaD
Tretinoin—Depression—Lisinopril—dilated cardiomyopathy	0.00126	0.00247	CcSEcCtD
Tretinoin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00126	0.00246	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00125	0.00245	CcSEcCtD
Tretinoin—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00125	0.00244	CcSEcCtD
Tretinoin—Rash—Spironolactone—dilated cardiomyopathy	0.00125	0.00244	CcSEcCtD
Tretinoin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00125	0.00243	CcSEcCtD
Tretinoin—RXRA—a6b1 and a6b4 Integrin signaling—ITGB1—dilated cardiomyopathy	0.00124	0.00385	CbGpPWpGaD
Tretinoin—Renal failure—Lisinopril—dilated cardiomyopathy	0.00124	0.00243	CcSEcCtD
Tretinoin—Vision blurred—Furosemide—dilated cardiomyopathy	0.00124	0.00243	CcSEcCtD
Tretinoin—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00124	0.00242	CcSEcCtD
Tretinoin—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00124	0.00242	CcSEcCtD
Tretinoin—Headache—Spironolactone—dilated cardiomyopathy	0.00124	0.00242	CcSEcCtD
Tretinoin—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00123	0.0024	CcSEcCtD
Tretinoin—Anaemia—Furosemide—dilated cardiomyopathy	0.00122	0.00238	CcSEcCtD
Tretinoin—Sweating—Lisinopril—dilated cardiomyopathy	0.00121	0.00237	CcSEcCtD
Tretinoin—Agitation—Furosemide—dilated cardiomyopathy	0.00121	0.00237	CcSEcCtD
Tretinoin—Haematuria—Lisinopril—dilated cardiomyopathy	0.00121	0.00236	CcSEcCtD
Tretinoin—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00119	0.00233	CcSEcCtD
Tretinoin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00119	0.00232	CcSEcCtD
Tretinoin—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00118	0.00231	CcSEcCtD
Tretinoin—Nausea—Spironolactone—dilated cardiomyopathy	0.00117	0.0023	CcSEcCtD
Tretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.00116	0.00358	CbGpPWpGaD
Tretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.00116	0.00358	CbGpPWpGaD
Tretinoin—CYP1A1—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.00115	0.00357	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.00114	0.00353	CbGpPWpGaD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.00114	0.00352	CbGpPWpGaD
Tretinoin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00114	0.00222	CcSEcCtD
Tretinoin—CYP1A1—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00113	0.0035	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.00113	0.0035	CbGpPWpGaD
Tretinoin—Hallucination—Lisinopril—dilated cardiomyopathy	0.00113	0.00221	CcSEcCtD
Tretinoin—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00113	0.0022	CcSEcCtD
Tretinoin—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00112	0.00219	CcSEcCtD
Tretinoin—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00112	0.00219	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00111	0.00218	CcSEcCtD
Tretinoin—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00111	0.00218	CcSEcCtD
Tretinoin—RXRA—a6b1 and a6b4 Integrin signaling—RPS6KB1—dilated cardiomyopathy	0.00111	0.00342	CbGpPWpGaD
Tretinoin—RXRA—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.0011	0.0034	CbGpPWpGaD
Tretinoin—Dry mouth—Furosemide—dilated cardiomyopathy	0.0011	0.00215	CcSEcCtD
Tretinoin—Confusional state—Furosemide—dilated cardiomyopathy	0.00108	0.00212	CcSEcCtD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.00108	0.00335	CbGpPWpGaD
Tretinoin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00108	0.0021	CcSEcCtD
Tretinoin—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00107	0.0021	CcSEcCtD
Tretinoin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00106	0.00207	CcSEcCtD
Tretinoin—Shock—Furosemide—dilated cardiomyopathy	0.00106	0.00207	CcSEcCtD
Tretinoin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00105	0.00206	CcSEcCtD
Tretinoin—Flushing—Lisinopril—dilated cardiomyopathy	0.00105	0.00206	CcSEcCtD
Tretinoin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00105	0.00206	CcSEcCtD
Tretinoin—Skin disorder—Furosemide—dilated cardiomyopathy	0.00104	0.00204	CcSEcCtD
Tretinoin—RXRG—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.00104	0.00323	CbGpPWpGaD
Tretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.00104	0.00322	CbGpPWpGaD
Tretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.00104	0.00322	CbGpPWpGaD
Tretinoin—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00104	0.00203	CcSEcCtD
Tretinoin—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00103	0.00201	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00103	0.00318	CbGpPWpGaD
Tretinoin—Anorexia—Furosemide—dilated cardiomyopathy	0.00103	0.002	CcSEcCtD
Tretinoin—RARB—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.00102	0.00316	CbGpPWpGaD
Tretinoin—Chills—Lisinopril—dilated cardiomyopathy	0.00102	0.00199	CcSEcCtD
Tretinoin—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00101	0.00198	CcSEcCtD
Tretinoin—Hypotension—Furosemide—dilated cardiomyopathy	0.001	0.00196	CcSEcCtD
Tretinoin—Alopecia—Lisinopril—dilated cardiomyopathy	0.001	0.00196	CcSEcCtD
Tretinoin—RXRA—a6b1 and a6b4 Integrin signaling—RAC1—dilated cardiomyopathy	0.001	0.00309	CbGpPWpGaD
Tretinoin—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000995	0.00195	CcSEcCtD
Tretinoin—Erythema—Lisinopril—dilated cardiomyopathy	0.000989	0.00193	CcSEcCtD
Tretinoin—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000989	0.00193	CcSEcCtD
Tretinoin—RARA—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.00098	0.00303	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.00098	0.00303	CbGpPWpGaD
Tretinoin—Flatulence—Lisinopril—dilated cardiomyopathy	0.000974	0.0019	CcSEcCtD
Tretinoin—Tension—Lisinopril—dilated cardiomyopathy	0.00097	0.0019	CcSEcCtD
Tretinoin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000966	0.00189	CcSEcCtD
Tretinoin—Nervousness—Lisinopril—dilated cardiomyopathy	0.00096	0.00188	CcSEcCtD
Tretinoin—Back pain—Lisinopril—dilated cardiomyopathy	0.000956	0.00187	CcSEcCtD
Tretinoin—Somnolence—Furosemide—dilated cardiomyopathy	0.000956	0.00187	CcSEcCtD
Tretinoin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000935	0.00183	CcSEcCtD
Tretinoin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000932	0.00182	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000928	0.00182	CcSEcCtD
Tretinoin—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—dilated cardiomyopathy	0.000928	0.00287	CbGpPWpGaD
Tretinoin—Fatigue—Furosemide—dilated cardiomyopathy	0.000927	0.00181	CcSEcCtD
Tretinoin—Tremor—Lisinopril—dilated cardiomyopathy	0.000926	0.00181	CcSEcCtD
Tretinoin—Pain—Furosemide—dilated cardiomyopathy	0.00092	0.0018	CcSEcCtD
Tretinoin—Constipation—Furosemide—dilated cardiomyopathy	0.00092	0.0018	CcSEcCtD
Tretinoin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000917	0.00179	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000916	0.00283	CbGpPWpGaD
Tretinoin—Anaemia—Lisinopril—dilated cardiomyopathy	0.000914	0.00179	CcSEcCtD
Tretinoin—CRABP2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000912	0.00282	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000912	0.00282	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000912	0.00282	CbGpPWpGaD
Tretinoin—Malaise—Lisinopril—dilated cardiomyopathy	0.000892	0.00174	CcSEcCtD
Tretinoin—RXRG—Adipogenesis—FAS—dilated cardiomyopathy	0.000891	0.00276	CbGpPWpGaD
Tretinoin—NR0B1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000888	0.00275	CbGpPWpGaD
Tretinoin—Syncope—Lisinopril—dilated cardiomyopathy	0.000887	0.00173	CcSEcCtD
Tretinoin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000886	0.00173	CcSEcCtD
Tretinoin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000879	0.00172	CcSEcCtD
Tretinoin—Palpitations—Lisinopril—dilated cardiomyopathy	0.000874	0.00171	CcSEcCtD
Tretinoin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—dilated cardiomyopathy	0.000872	0.0027	CbGpPWpGaD
Tretinoin—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000869	0.0017	CcSEcCtD
Tretinoin—Cough—Lisinopril—dilated cardiomyopathy	0.000863	0.00169	CcSEcCtD
Tretinoin—ALDH1A1—Metabolism—TAZ—dilated cardiomyopathy	0.000857	0.00265	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—TAZ—dilated cardiomyopathy	0.000857	0.00265	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—TAZ—dilated cardiomyopathy	0.000857	0.00265	CbGpPWpGaD
Tretinoin—Urticaria—Furosemide—dilated cardiomyopathy	0.000854	0.00167	CcSEcCtD
Tretinoin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00085	0.00166	CcSEcCtD
Tretinoin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00085	0.00166	CcSEcCtD
Tretinoin—Chest pain—Lisinopril—dilated cardiomyopathy	0.000842	0.00165	CcSEcCtD
Tretinoin—Myalgia—Lisinopril—dilated cardiomyopathy	0.000842	0.00165	CcSEcCtD
Tretinoin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000842	0.00165	CcSEcCtD
Tretinoin—Anxiety—Lisinopril—dilated cardiomyopathy	0.000839	0.00164	CcSEcCtD
Tretinoin—RARA—Adipogenesis—FAS—dilated cardiomyopathy	0.000838	0.00259	CbGpPWpGaD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000836	0.00163	CcSEcCtD
Tretinoin—RXRG—Adipogenesis—AGT—dilated cardiomyopathy	0.000835	0.00258	CbGpPWpGaD
Tretinoin—Discomfort—Lisinopril—dilated cardiomyopathy	0.000832	0.00163	CcSEcCtD
Tretinoin—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000823	0.00161	CcSEcCtD
Tretinoin—Confusional state—Lisinopril—dilated cardiomyopathy	0.000814	0.00159	CcSEcCtD
Tretinoin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000807	0.00158	CcSEcCtD
Tretinoin—Oedema—Lisinopril—dilated cardiomyopathy	0.000807	0.00158	CcSEcCtD
Tretinoin—Infection—Lisinopril—dilated cardiomyopathy	0.000802	0.00157	CcSEcCtD
Tretinoin—Shock—Lisinopril—dilated cardiomyopathy	0.000794	0.00155	CcSEcCtD
Tretinoin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000792	0.00155	CcSEcCtD
Tretinoin—CYP1A1—Oxidative Stress—SOD2—dilated cardiomyopathy	0.00079	0.00245	CbGpPWpGaD
Tretinoin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00079	0.00154	CcSEcCtD
Tretinoin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000787	0.00154	CcSEcCtD
Tretinoin—RARA—Adipogenesis—AGT—dilated cardiomyopathy	0.000785	0.00243	CbGpPWpGaD
Tretinoin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000784	0.00153	CcSEcCtD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000781	0.00242	CbGpPWpGaD
Tretinoin—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00078	0.00153	CcSEcCtD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.000779	0.00241	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—SDHA—dilated cardiomyopathy	0.000775	0.0024	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—SDHA—dilated cardiomyopathy	0.000775	0.0024	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—SDHA—dilated cardiomyopathy	0.000775	0.0024	CbGpPWpGaD
Tretinoin—Asthenia—Furosemide—dilated cardiomyopathy	0.000772	0.00151	CcSEcCtD
Tretinoin—Anorexia—Lisinopril—dilated cardiomyopathy	0.000769	0.0015	CcSEcCtD
Tretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	0.000768	0.00237	CbGpPWpGaD
Tretinoin—Pruritus—Furosemide—dilated cardiomyopathy	0.000761	0.00149	CcSEcCtD
Tretinoin—CYP1A1—Oxidative Stress—GPX1—dilated cardiomyopathy	0.000754	0.00233	CbGpPWpGaD
Tretinoin—Hypotension—Lisinopril—dilated cardiomyopathy	0.000754	0.00147	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—LMNA—dilated cardiomyopathy	0.000747	0.00231	CbGpPWpGaD
Tretinoin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000736	0.00144	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000735	0.00144	CcSEcCtD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000735	0.00227	CbGpPWpGaD
Tretinoin—Insomnia—Lisinopril—dilated cardiomyopathy	0.00073	0.00143	CcSEcCtD
Tretinoin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000724	0.00142	CcSEcCtD
Tretinoin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000719	0.00141	CcSEcCtD
Tretinoin—Somnolence—Lisinopril—dilated cardiomyopathy	0.000717	0.0014	CcSEcCtD
Tretinoin—RARG—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000716	0.00221	CbGpPWpGaD
Tretinoin—Dizziness—Furosemide—dilated cardiomyopathy	0.000711	0.00139	CcSEcCtD
Tretinoin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00071	0.00139	CcSEcCtD
Tretinoin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000701	0.00137	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000697	0.00136	CcSEcCtD
Tretinoin—Fatigue—Lisinopril—dilated cardiomyopathy	0.000696	0.00136	CcSEcCtD
Tretinoin—RXRA—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000694	0.00215	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—CD36—dilated cardiomyopathy	0.00069	0.00214	CbGpPWpGaD
Tretinoin—Pain—Lisinopril—dilated cardiomyopathy	0.00069	0.00135	CcSEcCtD
Tretinoin—Constipation—Lisinopril—dilated cardiomyopathy	0.00069	0.00135	CcSEcCtD
Tretinoin—Vomiting—Furosemide—dilated cardiomyopathy	0.000684	0.00134	CcSEcCtD
Tretinoin—NR0B1—Gene Expression—NR3C2—dilated cardiomyopathy	0.000681	0.00211	CbGpPWpGaD
Tretinoin—Rash—Furosemide—dilated cardiomyopathy	0.000678	0.00133	CcSEcCtD
Tretinoin—Dermatitis—Furosemide—dilated cardiomyopathy	0.000677	0.00132	CcSEcCtD
Tretinoin—Headache—Furosemide—dilated cardiomyopathy	0.000674	0.00132	CcSEcCtD
Tretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—dilated cardiomyopathy	0.000672	0.00208	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000666	0.00206	CbGpPWpGaD
Tretinoin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000665	0.0013	CcSEcCtD
Tretinoin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00066	0.00129	CcSEcCtD
Tretinoin—RXRG—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000655	0.00203	CbGpPWpGaD
Tretinoin—CYP4A11—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000654	0.00202	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000642	0.00199	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000642	0.00199	CbGpPWpGaD
Tretinoin—Urticaria—Lisinopril—dilated cardiomyopathy	0.000641	0.00125	CcSEcCtD
Tretinoin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000641	0.00198	CbGpPWpGaD
Tretinoin—Nausea—Furosemide—dilated cardiomyopathy	0.000639	0.00125	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000639	0.00198	CbGpPWpGaD
Tretinoin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000638	0.00125	CcSEcCtD
Tretinoin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000638	0.00125	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.00063	0.00195	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00062	0.00192	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000616	0.0019	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000616	0.0019	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000616	0.0019	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000604	0.00187	CbGpPWpGaD
Tretinoin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000594	0.00116	CcSEcCtD
Tretinoin—CYP4A11—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000589	0.00182	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000583	0.0018	CbGpPWpGaD
Tretinoin—Asthenia—Lisinopril—dilated cardiomyopathy	0.000579	0.00113	CcSEcCtD
Tretinoin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000577	0.00178	CbGpPWpGaD
Tretinoin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000571	0.00112	CcSEcCtD
Tretinoin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000552	0.00108	CcSEcCtD
Tretinoin—RARG—Gene Expression—NR3C2—dilated cardiomyopathy	0.000549	0.0017	CbGpPWpGaD
Tretinoin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000534	0.00104	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000522	0.00161	CbGpPWpGaD
Tretinoin—RXRA—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000519	0.00161	CbGpPWpGaD
Tretinoin—Vomiting—Lisinopril—dilated cardiomyopathy	0.000513	0.001	CcSEcCtD
Tretinoin—RXRA—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000511	0.00158	CbGpPWpGaD
Tretinoin—Rash—Lisinopril—dilated cardiomyopathy	0.000509	0.000995	CcSEcCtD
Tretinoin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000508	0.000994	CcSEcCtD
Tretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000508	0.00157	CbGpPWpGaD
Tretinoin—Headache—Lisinopril—dilated cardiomyopathy	0.000505	0.000988	CcSEcCtD
Tretinoin—RXRG—Gene Expression—NR3C2—dilated cardiomyopathy	0.000502	0.00155	CbGpPWpGaD
Tretinoin—CYP1A1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000501	0.00155	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—NR3C2—dilated cardiomyopathy	0.000492	0.00152	CbGpPWpGaD
Tretinoin—Nausea—Lisinopril—dilated cardiomyopathy	0.000479	0.000937	CcSEcCtD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000473	0.00146	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000473	0.00146	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—NR3C2—dilated cardiomyopathy	0.000472	0.00146	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—NR3C2—dilated cardiomyopathy	0.000472	0.00146	CbGpPWpGaD
Tretinoin—RXRA—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000467	0.00145	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00046	0.00142	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00046	0.00142	CbGpPWpGaD
Tretinoin—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000459	0.00142	CbGpPWpGaD
Tretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000457	0.00142	CbGpPWpGaD
Tretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—dilated cardiomyopathy	0.000455	0.00141	CbGpPWpGaD
Tretinoin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000441	0.00137	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—FAS—dilated cardiomyopathy	0.000437	0.00135	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—NPPA—dilated cardiomyopathy	0.000428	0.00132	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00042	0.0013	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000417	0.00129	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000415	0.00128	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000415	0.00128	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—AGT—dilated cardiomyopathy	0.000409	0.00126	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000408	0.00126	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000408	0.00126	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.0004	0.00124	CbGpPWpGaD
Tretinoin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000397	0.00123	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00038	0.00117	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—TNF—dilated cardiomyopathy	0.000378	0.00117	CbGpPWpGaD
Tretinoin—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000374	0.00116	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—TNF—dilated cardiomyopathy	0.000356	0.0011	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.00035	0.00108	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ANKRD1—dilated cardiomyopathy	0.000348	0.00108	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—NPPA—dilated cardiomyopathy	0.000345	0.00107	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000333	0.00103	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—TAZ—dilated cardiomyopathy	0.000327	0.00101	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000326	0.00101	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000321	0.000993	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000321	0.000993	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—NPPA—dilated cardiomyopathy	0.000315	0.000975	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000315	0.000975	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000315	0.000973	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00031	0.000959	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—NPPA—dilated cardiomyopathy	0.000309	0.000957	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ANKRD1—dilated cardiomyopathy	0.000304	0.000941	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—NPPA—dilated cardiomyopathy	0.000296	0.000917	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—NPPA—dilated cardiomyopathy	0.000296	0.000917	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—SDHA—dilated cardiomyopathy	0.000296	0.000915	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000293	0.000905	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000292	0.000902	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000286	0.000886	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—TAZ—dilated cardiomyopathy	0.000286	0.000885	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000284	0.000879	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—dilated cardiomyopathy	0.000282	0.000872	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ANKRD1—dilated cardiomyopathy	0.000276	0.000854	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000274	0.000849	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000273	0.000843	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000267	0.000827	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000261	0.000809	CbGpPWpGaD
Tretinoin—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.00026	0.000803	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—TAZ—dilated cardiomyopathy	0.000259	0.000803	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—SDHA—dilated cardiomyopathy	0.000259	0.0008	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000254	0.000786	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—NR3C2—dilated cardiomyopathy	0.000246	0.000761	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—SDHA—dilated cardiomyopathy	0.000235	0.000726	CbGpPWpGaD
Tretinoin—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000234	0.000723	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000231	0.000716	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000229	0.000708	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000224	0.000692	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000224	0.000692	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000218	0.000673	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000213	0.000659	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000213	0.000659	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—GPX1—dilated cardiomyopathy	0.000211	0.000651	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—GPX1—dilated cardiomyopathy	0.000211	0.000651	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—GPX1—dilated cardiomyopathy	0.000211	0.000651	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000209	0.000645	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—CD36—dilated cardiomyopathy	0.000205	0.000634	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—CD36—dilated cardiomyopathy	0.000205	0.000634	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—CD36—dilated cardiomyopathy	0.000205	0.000634	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	0.000202	0.000626	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	0.00019	0.000588	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000185	0.000573	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—TNF—dilated cardiomyopathy	0.000185	0.000573	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—AGT—dilated cardiomyopathy	0.000185	0.000571	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—AGT—dilated cardiomyopathy	0.000185	0.000571	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—AGT—dilated cardiomyopathy	0.000185	0.000571	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000183	0.000566	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00018	0.000558	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000176	0.000544	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000175	0.000542	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	0.000174	0.000539	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	0.000172	0.000532	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000158	0.00049	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000158	0.000488	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	0.000158	0.000488	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—CD36—dilated cardiomyopathy	0.000156	0.000483	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—NPPA—dilated cardiomyopathy	0.000154	0.000478	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	0.00015	0.000463	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—RAC1—dilated cardiomyopathy	0.000147	0.000455	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	0.000146	0.000452	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000143	0.000443	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000143	0.000443	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	0.000141	0.000435	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000139	0.000431	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000138	0.000427	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	0.000137	0.000425	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000136	0.000421	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	0.00013	0.000402	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	0.000127	0.000393	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000127	0.000392	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000126	0.000388	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	0.000124	0.000384	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	0.000119	0.000368	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	0.000117	0.000363	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	0.000108	0.000333	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000103	0.000319	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—RAF1—dilated cardiomyopathy	9.75e-05	0.000302	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	9.69e-05	0.0003	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	8.76e-05	0.000271	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.28e-05	0.000256	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GPX1—dilated cardiomyopathy	8.04e-05	0.000249	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CD36—dilated cardiomyopathy	7.83e-05	0.000242	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.16e-05	0.000222	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AGT—dilated cardiomyopathy	7.05e-05	0.000218	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GPX1—dilated cardiomyopathy	7.03e-05	0.000217	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.97e-05	0.000216	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CD36—dilated cardiomyopathy	6.84e-05	0.000212	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	6.8e-05	0.00021	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—EGFR—dilated cardiomyopathy	6.69e-05	0.000207	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.57e-05	0.000203	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.39e-05	0.000198	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	6.39e-05	0.000198	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GPX1—dilated cardiomyopathy	6.37e-05	0.000197	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TNF—dilated cardiomyopathy	6.37e-05	0.000197	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.28e-05	0.000194	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CD36—dilated cardiomyopathy	6.21e-05	0.000192	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AGT—dilated cardiomyopathy	6.16e-05	0.000191	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	5.78e-05	0.000179	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.76e-05	0.000178	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AGT—dilated cardiomyopathy	5.59e-05	0.000173	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.34e-05	0.000165	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.2e-05	0.000161	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.69e-05	0.000145	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	4.67e-05	0.000144	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	4.55e-05	0.000141	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	4.28e-05	0.000132	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	4.17e-05	0.000129	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	4.1e-05	0.000127	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	3.75e-05	0.000116	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	3.45e-05	0.000107	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	3.38e-05	0.000104	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	3.36e-05	0.000104	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	3.29e-05	0.000102	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	3.19e-05	9.87e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	3.11e-05	9.61e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	3.03e-05	9.37e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	2.96e-05	9.16e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	2.92e-05	9.05e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	2.85e-05	8.81e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	2.8e-05	8.65e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	2.56e-05	7.93e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	2.38e-05	7.36e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	2.32e-05	7.17e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.09e-05	6.46e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.57e-05	4.86e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.53e-05	4.73e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.38e-05	4.26e-05	CbGpPWpGaD
